Form4insider filings, from the source

SEC Form 4/A · accession 0001615774-18-002857

Emmaus Life Sciences, Inc. · EMMA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Apr 4, 2018
Accepted (ET)
Apr 24, 2018 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 4, 2018A25,000$0.00A148,026D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F2$1.55Apr 4, 2018A75,000A—Apr 4, 2028Common Stock75,00075,000D
Employee Stock Option (right to buy)F3$1.99Apr 16, 2018A50,000A—Apr 16, 2028Common Stock50,00050,000D

Explanation of responses